A leader with a track record of driving innovations and transforming healthcare with data intelligence
Melax Tech, a world leader in biomedical natural language processing (NLP) technology, appoints Xiaoyan Wang, PhD., as Chief Scientific Officer of the company. Dr. Wang has spent two decades committed to driving innovations in healthcare AI modeling and transforming health care with data intelligence.
Xiaoyan Wang, Ph.D., served as the Vice President of Healthcare Analytics, Informatics, and Biopharma Solutions at Sema4 for three years, where she led the development of clinical evidence-generation platforms and clinical research in oncology, immunology, cardiovascular, respiratory, neurology, and rare diseases. Before joining the biopharma industry, Dr. Wang was a faculty member and principal investigator at the University of Connecticut, UConn Health Center, and Mount Sinai Health Systems bridging research, healthcare services, and teaching.